Remove Academics Remove COPD Remove Outcomes
article thumbnail

A Brilliant Comment Makes the Study of the Week

Sensible Medicine

On yesterday’s podcast , I talked with Bobby Yeh, an academic cardiologist who made a compelling case for enhancing credibility of observational research. This is a common probably insurmountable problem with morbidities, such as hypertension, diabetes , COPD , etc. Please do listen.

article thumbnail

SGEM Xtra: This is My Life – Centralization of Rural Emergency Healthcare

The Skeptics' Guide to EM

2023 Apr Guest Skeptics: Dr. Louella Vaugh is an internist practising as a hospitalist physician at an academic centre in London, UK with a special interest in smaller, rural and remote healthcare. The main outcome was the adjusted odds ratio for in-hospital mortality and hazard ratio for 30-day mortality with some pre-specified subgroups.

Stroke 57
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Latest in Critical Care, 10/23/23 (Issue #17)

PulmCCM

Over the years, dozens of copycat studies (which are relatively easy for academics to churn out) created a steady, low-quality drumbeat of negativity toward Zosyn. Read in JAMA Does Paxlovid Improve Covid-19 Outcomes in the Omicron Era? Even people with COPD or asthma under age 50 did not benefit from Paxlovid, in that analysis.

article thumbnail

The Latest in Critical Care, 9/28/23 (Issue #15)

PulmCCM

Systemic corticosteroids (such as intravenous dexamethasone) improve outcomes in severe pneumonia due to SARS-CoV-2 infection. It makes sense that inhaled steroids might improve outcomes from less severe infections. Do inhaled steroids improve Covid pneumonia? About two thirds of patients in each arm were vaccinated.

COPD 95